Literature DB >> 15716646

Guidelines for managing pressure ulcers with negative pressure wound therapy.

Subhas Gupta1, Mona Baharestani, Sharon Baranoski, Jean de Leon, Scott J Engel, Susan Mendez-Eastman, Jeffery A Niezgoda, Matthew Q Pompeo.   

Abstract

Pressure ulcers are a serious health issue, leading to clinical, financial, and emotional challenges. Numerous treatment modalities are available to promote wound healing, yet clinicians may be unsure how to incorporate these treatment options into an overall plan of care for the patient with a pressure ulcer. A consensus panel of experienced wound care clinicians convened in July 2004 to review the mechanisms of action and research basis for one such treatment modality: negative pressure wound therapy. After answering key questions about this modality, they developed an algorithm to assist the clinician in making decisions about using negative pressure wound therapy appropriately in patients with Stage III and Stage IV pressure ulcers.

Entities:  

Mesh:

Year:  2004        PMID: 15716646     DOI: 10.1097/00129334-200411002-00001

Source DB:  PubMed          Journal:  Adv Skin Wound Care        ISSN: 1527-7941            Impact factor:   2.347


  16 in total

Review 1.  Optimal use of negative pressure wound therapy in treating pressure ulcers.

Authors:  Subhas Gupta; Shigeru Ichioka
Journal:  Int Wound J       Date:  2012-08       Impact factor: 3.315

2.  Relationship of inferior gluteal nerves and vessels: target for application of stimulation devices for the prevention of pressure ulcers in spinal cord injury.

Authors:  Anthony F Skalak; Michael F McGee; Gary Wu; Kath Bogie
Journal:  Surg Radiol Anat       Date:  2007-11-30       Impact factor: 1.246

Review 3.  Comprehensive management of pressure ulcers in spinal cord injury: current concepts and future trends.

Authors:  Erwin A Kruger; Marilyn Pires; Yvette Ngann; Michelle Sterling; Salah Rubayi
Journal:  J Spinal Cord Med       Date:  2013-05-21       Impact factor: 1.985

Review 4.  Vacuum-assisted closure home care training: a process to link education to improved patient outcomes.

Authors:  Kevin Y Woo; R Gary Sibbald
Journal:  Int Wound J       Date:  2008-06       Impact factor: 3.315

5.  Negative Pressure Wound Therapy With Instillation (NPWTi) Better Reduces Post-debridement Bioburden in Chronically Infected Lower Extremity Wounds Than NPWT Alone.

Authors:  S G Goss; J A Schwartz; F Facchin; E Avdagic; C Gendics; J C Lantis
Journal:  J Am Coll Clin Wound Spec       Date:  2014-02-20

6.  VAC Therapy in Large Infected Sacral Pressure Ulcer Grade IV-Can Be an Alternative to Flap Reconstruction?

Authors:  R K Batra; Veena Aseeja
Journal:  Indian J Surg       Date:  2012-12-14       Impact factor: 0.656

7.  Activated protein C to heal pressure ulcers.

Authors:  Aruna Wijewardena; Sepehr S Lajevardi; Elle Vandervord; John Vandervord; Thomas C Lang; Gregory Fulcher; Christopher J Jackson
Journal:  Int Wound J       Date:  2014-09-03       Impact factor: 3.315

8.  SHEA/APIC guideline: infection prevention and control in the long-term care facility, July 2008.

Authors:  Philip W Smith; Gail Bennett; Suzanne Bradley; Paul Drinka; Ebbing Lautenbach; James Marx; Lona Mody; Lindsay Nicolle; Kurt Stevenson
Journal:  Infect Control Hosp Epidemiol       Date:  2008-09       Impact factor: 3.254

Review 9.  V.A.C. Therapy in the management of paediatric wounds: clinical review and experience.

Authors:  Mona Baharestani; Ibrahim Amjad; Kim Bookout; Tatjana Fleck; Allen Gabriel; David Kaufman; Shannon Stone McCord; Donald C Moores; Oluyinka O Olutoye; Jorge D Salazar; David H Song; Steven Teich; Subhas Gupta
Journal:  Int Wound J       Date:  2009-08       Impact factor: 3.315

10.  Negative pressure wound therapy for a large skin ulcer following repair of huge myeloschisis with kyphosis in a newborn.

Authors:  Hiroyuki Katano; Kazuhiro Toriyama; Yusuke Nishikawa; Koichi Ito; Akimichi Morita; Yuzuru Kamei; Kazuo Yamada
Journal:  Childs Nerv Syst       Date:  2013-05-25       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.